Literature DB >> 19731080

Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis.

Kory W Jasperson1, Thuy M Vu, Angela L Schwab, Deborah W Neklason, Miguel A Rodriguez-Bigas, Randall W Burt, Jeffrey N Weitzel.   

Abstract

To characterize the frequency of germline mutations associated with Lynch syndrome and review the potential expanded differential diagnoses in very early onset colorectal cancer (CRC) cases without apparent polyposis. Retrospectively reviewed medical records of 96 probands with CRC diagnosed prior to age 36 from three cancer centers. Determined the frequency of germline mutations in probands meeting different clinical criteria used to identify Lynch syndrome. Three of 46 (6.5%) single case indicators (probands without additional personal or family history suspicious for Lynch syndrome) were identified to carry a deleterious or suspected deleterious mismatch repair (MMR) mutation compared with 10 of 19 (52.6%) in the cases meeting at least one additional revised Bethesda guideline, and 11 of 15 (73.3%) in the cases meeting Amsterdam criteria. Two families without MMR mutations were documented to have a germline APC or TP53 mutation after additional clinical features were identified. Our results suggest that single cases of CRC (those without additional personal or family history suspicious of Lynch syndrome) diagnosed prior to age 36 infrequently have identifiable MMR mutations, especially when compared to cases meeting additional criteria. Careful attention to evolving or additional clinical features is warranted and may lead to an alternate genetic diagnosis in families with early onset CRC.

Entities:  

Mesh:

Year:  2010        PMID: 19731080      PMCID: PMC3620042          DOI: 10.1007/s10689-009-9290-4

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  28 in total

1.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).

Authors:  H F Vasen; J P Mecklin; P M Khan; H T Lynch
Journal:  Dis Colon Rectum       Date:  1991-05       Impact factor: 4.585

2.  A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines.

Authors:  M A Rodriguez-Bigas; C R Boland; S R Hamilton; D E Henson; J R Jass; P M Khan; H Lynch; M Perucho; T Smyrk; L Sobin; S Srivastava
Journal:  J Natl Cancer Inst       Date:  1997-12-03       Impact factor: 13.506

3.  Cancer risk in mutation carriers of DNA-mismatch-repair genes.

Authors:  M Aarnio; R Sankila; E Pukkala; R Salovaara; L A Aaltonen; A de la Chapelle; P Peltomäki; J P Mecklin; H J Järvinen
Journal:  Int J Cancer       Date:  1999-04-12       Impact factor: 7.396

4.  Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk.

Authors:  Marina E Croitoru; Sean P Cleary; Nando Di Nicola; Michael Manno; Teresa Selander; Melyssa Aronson; Mark Redston; Michelle Cotterchio; Julia Knight; Robert Gryfe; Steven Gallinger
Journal:  J Natl Cancer Inst       Date:  2004-11-03       Impact factor: 13.506

5.  Cancer risk associated with germline DNA mismatch repair gene mutations.

Authors:  M G Dunlop; S M Farrington; A D Carothers; A H Wyllie; L Sharp; J Burn; B Liu; K W Kinzler; B Vogelstein
Journal:  Hum Mol Genet       Date:  1997-01       Impact factor: 6.150

6.  Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls.

Authors:  S M Farrington; J Lin-Goerke; J Ling; Y Wang; J D Burczak; D J Robbins; M G Dunlop
Journal:  Am J Hum Genet       Date:  1998-09       Impact factor: 11.025

7.  Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.

Authors:  Yvonne M C Hendriks; Anja Wagner; Hans Morreau; Fred Menko; Astrid Stormorken; Franz Quehenberger; Lodewijk Sandkuijl; Pal Møller; Maurizio Genuardi; Hans Van Houwelingen; Carli Tops; Marjo Van Puijenbroek; Paul Verkuijlen; Gemma Kenter; Anneke Van Mil; Hanne Meijers-Heijboer; Gita B Tan; Martijn H Breuning; Riccardo Fodde; Juul Th Wijnen; Annette H J T Bröcker-Vriends; Hans Vasen
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

8.  Genetic instability occurs in the majority of young patients with colorectal cancer.

Authors:  B Liu; S M Farrington; G M Petersen; S R Hamilton; R Parsons; N Papadopoulos; T Fujiwara; J Jen; K W Kinzler; A H Wyllie; B Vogelstein; M G Dunlop
Journal:  Nat Med       Date:  1995-04       Impact factor: 53.440

9.  Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

Authors:  H F Vasen; J T Wijnen; F H Menko; J H Kleibeuker; B G Taal; G Griffioen; F M Nagengast; E H Meijers-Heijboer; L Bertario; L Varesco; M L Bisgaard; J Mohr; R Fodde; P M Khan
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

10.  MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease.

Authors:  C Pinto; I Veiga; M Pinheiro; B Mesquita; C Jeronimo; O Sousa; M Fragoso; L Santos; L Moreira-Dias; M Baptista; C Lopes; S Castedo; M R Teixeira
Journal:  Br J Cancer       Date:  2006-08-29       Impact factor: 7.640

View more
  10 in total

1.  MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer.

Authors:  María Dolores Giráldez; Francesc Balaguer; Luis Bujanda; Miriam Cuatrecasas; Jenifer Muñoz; Virginia Alonso-Espinaco; Mikel Larzabal; Anna Petit; Victoria Gonzalo; Teresa Ocaña; Leticia Moreira; José María Enríquez-Navascués; C Richard Boland; Ajay Goel; Antoni Castells; Sergi Castellví-Bel
Journal:  Clin Cancer Res       Date:  2010-10-05       Impact factor: 12.531

Review 2.  Early-onset colorectal cancer: a sporadic or inherited disease?

Authors:  Vittoria Stigliano; Lupe Sanchez-Mete; Aline Martayan; Marcello Anti
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

3.  Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.

Authors:  Matthew B Yurgelun; Serena Masciari; Victoria A Joshi; Rowena C Mercado; Noralane M Lindor; Steven Gallinger; John L Hopper; Mark A Jenkins; Daniel D Buchanan; Polly A Newcomb; John D Potter; Robert W Haile; Raju Kucherlapati; Sapna Syngal
Journal:  JAMA Oncol       Date:  2015-05       Impact factor: 31.777

Review 4.  Early-onset colorectal cancer: a separate subset of colorectal cancer.

Authors:  Irene Osorio Silla; Daniel Rueda; Yolanda Rodríguez; Juan Luis García; Felipe de la Cruz Vigo; José Perea
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 5.  Informing relatives of their genetic risk: an examination of the Belgian legal context.

Authors:  Amicia Phillips; Thomas Bronselaer; Pascal Borry; Ine Van Hoyweghen; Danya F Vears; Laurent Pasquier; Stefaan Callens
Journal:  Eur J Hum Genet       Date:  2022-01-08       Impact factor: 5.351

Review 6.  Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes.

Authors:  Nayiri M Kaissarian; Douglas Meyer; Chava Kimchi-Sarfaty
Journal:  J Natl Cancer Inst       Date:  2022-08-08       Impact factor: 11.816

7.  Early-onset colorectal cancer patients without family history are "at very low risk" for lynch syndrome.

Authors:  Vittoria Stigliano; Lupe Sanchez-Mete; Aline Martayan; Maria Diodoro; Beatrice Casini; Isabella Sperduti; Marcello Anti
Journal:  J Exp Clin Cancer Res       Date:  2014-01-02

8.  Acceleration of the DNA methylation clock among lynch syndrome-associated mutation carriers.

Authors:  Marta Cuadros; Carlos Cano; Sonia Garcia-Rodriguez; José Luis Martín; Antonio Poyatos-Andujar; Francisco Ruiz-Cabello; Susana Pedrinaci; Gema Durán; Manuel Benavides; María Dolores Bautista-Ojeda; Teresa Pereda; Maria Soledad Benitez-Cantos; Pedro Medina; Armando Blanco; Antonio Gonzalez; Paul Lizardi
Journal:  BMC Med Genomics       Date:  2022-03-04       Impact factor: 3.063

Review 9.  Population genomic screening: Ethical considerations to guide age at implementation.

Authors:  Scott J Spencer; Stephanie M Fullerton
Journal:  Front Genet       Date:  2022-10-04       Impact factor: 4.772

10.  Molecular Features and Methylation Status in Early Onset (≤40 Years) Colorectal Cancer: A Population Based, Case-Control Study.

Authors:  Giulia Magnani; Daniela Furlan; Nora Sahnane; Luca Reggiani Bonetti; Federica Domati; Monica Pedroni
Journal:  Gastroenterol Res Pract       Date:  2015-10-19       Impact factor: 2.260

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.